Paper published in a journal (Scientific congresses and symposiums)
A three-year double-blind placebo-controlled study of risedronate in postmenopausal osteoporosis
Taquet, AN; Clemmensen, B; Zegels, Brigitte et al.
1996In Osteoporosis International, 6 (S1), p. 262
Peer Reviewed verified by ORBi
 

Files


Full Text
A three-year double-blind placebo-controlled study of risedronate in postmenopausal osteoporosis.pdf
Publisher postprint (135.95 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Taquet, AN
Clemmensen, B
Zegels, Brigitte ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Ravin, P
Christiansen, C
Roumagnac, I
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
A three-year double-blind placebo-controlled study of risedronate in postmenopausal osteoporosis
Publication date :
1996
Event name :
World Congress on Osteoporosis
Event organizer :
European Foundation for Osteoporosis and Bone Diseases (EFFO) in cooperation with the National Osteoporosis Foundation (NOF)
Event place :
United States
Event date :
Du 18 mai 1996 au 23 mai 1996
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
6
Issue :
S1
Pages :
262
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 22 January 2013

Statistics


Number of views
72 (7 by ULiège)
Number of downloads
3 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi